Vimarsana
Biggest News Aggregation in the World

Page 23 - Nt Ears News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nt Ears. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nt Ears Today - Breaking & Trending Today

Enthesitis Linked to Dupilumab Use for Atopic Dermatitis - Vimarsana News

Enthesitis Linked to Dupilumab Use for Atopic Dermatitis

Musculoskeletal symptoms identified in some patients treated with dupilumab for atopic dermatitis could help further understanding of how enthesitis develops.

Leadless Dual-Chamber Pacemaker Clears Performance Hurdles - Vimarsana News

Leadless Dual-Chamber Pacemaker Clears Performance Hurdles

It's actually two leadless pacemakers, one atrial and the other ventricular, linked as if in a wireless network, that together maintained true AV synchronous pacing in a short-term study.

Sublingual Immunotherapy Stops Onset and Worsening of Asthma - Vimarsana News

Sublingual Immunotherapy Stops Onset and Worsening of Asthma

The French EfficAPSI study confirmed that sublingual liquid immunotherapy or "desensitization" reduces the risks for asthma onset and the worsening of asthma in patients with allergic rhinitis.

Dupilumab Curbs Acute COPD Exacerbations - Vimarsana News

Dupilumab Curbs Acute COPD Exacerbations

Patients treated with dupilumab for COPD also showed significant improvements in lung function at 12 and 52 weeks.

FDA Approves Upadacitinib (Rinvoq) for Crohn's Disease - Vimarsana News

FDA Approves Upadacitinib (Rinvoq) for Crohn's Disease

The oral JAK inhibitor is for adults with moderately to severely active Crohn's disease whose condition failed to respond adequately or who can't tolerate one or more TNF inhibitors.